NYU Langone Health and Deerfield Management Launch Amethyst Innovations with Up To $130 Million to Accelerate Commercialization of Biomedical Discoveries

NYU Langone Health and Deerfield Management Company, a healthcare investment firm, today announced the launch of a research and development collaboration designed to accelerate the commercialization of biomedical discoveries.

Through a newly formed company called Amethyst Innovations, LLC, Deerfield has committed up to $130 million over the next 10 years, along with additional scientific and operational support, including access to the Deerfield-founded Women in Science program, to advance the translation of NYU Langone's cutting-edge biomedical research in a broad range of areas.